Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Jacobs, GE"" wg kryterium: Autor


Tytuł:
R.K. Jongensschool St. Jozef in Besoijen. Achterste rij van links naar rechts: van Delft (leraar), NN, Schapendonk, NN, NN, Pelgzin, NN, Tinus Mahieu, Passier, Koos van Os. 2e rij van achter: Bruurmijn, Verhagen, Henkelman (met das), Bruurmijn. De andere namen zijn onbekend
Autorzy:
Jacobs, Gebroeders, Amsterdam
Pokaż więcej
Dostęp URL:
https://www.europeana.eu/item/2021627/archieven_en_collecties_beeld_beeldbank_detail_cdf9dd9a_fba1_92e1_6163_ca2055dacd90?utm_source=api&utm_medium=api&utm_campaign=YuvuWBeCa  Link otwiera się w nowym oknie
Tytuł:
Symbiotic bacteria (Erwinia sp.) in the gut of Frankliniella occidentalis (Thysanoptera: Thripidae) do not affect its ability to transmit tospovirus
Autorzy:
De Vries, Egbert
Van de Wetering, Fennet
Van der Hoek, Marieke M.
Jacobs, Gerrit
Breeuwer, Johannes A.J.
Pokaż więcej
Dostęp URL:
https://www.europeana.eu/item/336/uuid_3d197837_da1b_44e9_9fc8_028f4c4ce373?utm_source=api&utm_medium=api&utm_campaign=YuvuWBeCa  Link otwiera się w nowym oknie
Tytuł:
Item response theory in early phase clinical trials: Utilization of a reference model to analyze the Montgomery-Åsberg Depression Rating Scale.
Autorzy:
Otto ME; Centre for Human Drug Research (CHDR), Leiden, The Netherlands.; Leiden Academic Centre for Drug Research (LACDR), Leiden University, Leiden, The Netherlands.
Bergmann KR; Centre for Human Drug Research (CHDR), Leiden, The Netherlands.
de Kam ML; Centre for Human Drug Research (CHDR), Leiden, The Netherlands.
Recourt K; Centre for Human Drug Research (CHDR), Leiden, The Netherlands.
Jacobs GE; Centre for Human Drug Research (CHDR), Leiden, The Netherlands.; Department of Psychiatry, Leiden University Medical Center (LUMC), Leiden, The Netherlands.
van Esdonk MJ; Centre for Human Drug Research (CHDR), Leiden, The Netherlands.
Pokaż więcej
Źródło:
CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2023 Oct; Vol. 12 (10), pp. 1425-1436. Date of Electronic Publication: 2023 Aug 10.
Typ publikacji:
Randomized Controlled Trial; Journal Article
MeSH Terms:
Depression*/drug therapy
Depressive Disorder, Major*/diagnosis
Depressive Disorder, Major*/drug therapy
Humans ; Double-Blind Method ; Surveys and Questionnaires ; Treatment Outcome ; Cross-Over Studies
Czasopismo naukowe
Tytuł:
Characterization of the central nervous system penetrant and selective purine P2X7 receptor antagonist JNJ-54175446 in patients with major depressive disorder.
Autorzy:
Recourt K; Centre for Human Drug Research, Leiden, the Netherlands. .; Department of Psychiatry, Leiden University Medical Center, Leiden, the Netherlands. .
de Boer P; Janssen Research and Development, a Division of Janssen Pharmaceutica N.V, Beerse, Belgium.
van der Ark P; Janssen Research and Development, a Division of Janssen Pharmaceutica N.V, Beerse, Belgium.
Benes H; Janssen Research and Development, a Division of Janssen Pharmaceutica N.V, Beerse, Belgium.
van Gerven JMA; Centre for Human Drug Research, Leiden, the Netherlands.; Department of Psychiatry, Leiden University Medical Center, Leiden, the Netherlands.
Ceusters M; Janssen Research and Development, a Division of Janssen Pharmaceutica N.V, Beerse, Belgium.
van Nueten L; Janssen Research and Development, a Division of Janssen Pharmaceutica N.V, Beerse, Belgium.
Drevets WC; Janssen Research and Development LLC, La Jolla, CA, USA.
Bhatacharya A; Janssen Research and Development LLC, La Jolla, CA, USA.
Browning M; University of Oxford, Oxford, UK.; Oxford Health NHS Trust, Oxford, UK.
Jacobs GE; Centre for Human Drug Research, Leiden, the Netherlands.; Department of Psychiatry, Leiden University Medical Center, Leiden, the Netherlands.
Pokaż więcej
Źródło:
Translational psychiatry [Transl Psychiatry] 2023 Jul 24; Vol. 13 (1), pp. 266. Date of Electronic Publication: 2023 Jul 24.
Typ publikacji:
Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Depressive Disorder, Major*/drug therapy
Depressive Disorder, Major*/diagnosis
Humans ; Purinergic P2X Receptor Antagonists/adverse effects ; Receptors, Purinergic P2X7 ; Central Nervous System ; Sleep Deprivation ; Dextroamphetamine
Czasopismo naukowe
Tytuł:
MTORC1 signaling as a biomarker in major depressive disorder and its pharmacological modulation by novel rapid-acting antidepressants.
Autorzy:
Cholewinski T; Centre for Human Drug Research, Leiden, The Netherlands.
Pereira D; Centre for Human Drug Research, Leiden, The Netherlands.
Moerland M; Centre for Human Drug Research, Leiden, The Netherlands.
Jacobs GE; Centre for Human Drug Research, Zernikedreef 8, 2333 CL Leiden, The Netherlands.
Pokaż więcej
Źródło:
Therapeutic advances in psychopharmacology [Ther Adv Psychopharmacol] 2021 Oct 28; Vol. 11, pp. 20451253211036814. Date of Electronic Publication: 2021 Oct 28 (Print Publication: 2021).
Typ publikacji:
Journal Article; Review
Czasopismo naukowe
Tytuł:
Transcranial magnetic stimulation as a translational biomarker for AMPA receptor modulation.
Autorzy:
O'Donnell P; Takeda Pharmaceuticals International, Inc., Cambridge, MA, USA. .; McLean Hospital, Department of Psychiatry, Harvard Medical School, Belmont, MA, USA. .
Dijkstra FM; Centre for Human Drug Research (CHDR), Leiden, The Netherlands.; Department of Psychiatry, Leiden University Medical Center, Leiden, The Netherlands.
Damar U; Neuromodulation Program, Department of Neurology and F.M. Kirby Center for Neurobiology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
Quanhong L; Takeda Pharmaceuticals International, Inc., Cambridge, MA, USA.
de Goede AA; Centre for Human Drug Research (CHDR), Leiden, The Netherlands.
Xu L; Takeda Pharmaceuticals International, Inc., Cambridge, MA, USA.
Pascual-Leone A; Neuromodulation Program, Department of Neurology and F.M. Kirby Center for Neurobiology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
Buhl DL; Takeda Pharmaceuticals International, Inc., Cambridge, MA, USA.
Zuiker R; Centre for Human Drug Research (CHDR), Leiden, The Netherlands.
Ruijs TQ; Centre for Human Drug Research (CHDR), Leiden, The Netherlands.
Heuberger JAAC; Centre for Human Drug Research (CHDR), Leiden, The Netherlands.
MacMullin P; Neuromodulation Program, Department of Neurology and F.M. Kirby Center for Neurobiology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
Lubell M; Takeda Pharmaceuticals International, Inc., Cambridge, MA, USA.
Asgharnejad M; Takeda Pharmaceuticals International, Inc., Cambridge, MA, USA.
Murthy V; Takeda Pharmaceuticals International, Inc., Cambridge, MA, USA.
Rotenberg A; Neuromodulation Program, Department of Neurology and F.M. Kirby Center for Neurobiology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
Jacobs GE; Centre for Human Drug Research (CHDR), Leiden, The Netherlands.; Department of Psychiatry, Leiden University Medical Center, Leiden, The Netherlands.
Rosen L; Takeda Pharmaceuticals International, Inc., Cambridge, MA, USA.
Pokaż więcej
Źródło:
Translational psychiatry [Transl Psychiatry] 2021 May 27; Vol. 11 (1), pp. 325. Date of Electronic Publication: 2021 May 27.
Typ publikacji:
Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Depressive Disorder, Major*
Transcranial Magnetic Stimulation*
Animals ; Female ; Male ; Rats ; Biomarkers ; Evoked Potentials, Motor ; Receptors, AMPA
Czasopismo naukowe
Tytuł:
A Study of Novel Exploratory Tools, Digital Technologies, and Central Nervous System Biomarkers to Characterize Unipolar Depression.
Autorzy:
Sverdlov O; Novartis Pharmaceuticals Corporation, East Hanover, NJ, United States.
Curcic J; Novartis Institutes for Biomedical Research, Basel, Switzerland.
Hannesdottir K; Novartis Institutes for Biomedical Research, Cambridge, MA, United States.
Gou L; Novartis Pharmaceuticals Corporation, East Hanover, NJ, United States.
De Luca V; Novartis Institutes for Biomedical Research, Basel, Switzerland.
Ambrosetti F; Novartis Institutes for Biomedical Research, Basel, Switzerland.
Zhang B; Department of Biostatistics, Bioinformatics and Biomathematics, Georgetown University, Washington, DC, United States.
Praestgaard J; Novartis Institutes for Biomedical Research, Cambridge, MA, United States.
Vallejo V; Novartis Institutes for Biomedical Research, Basel, Switzerland.
Dolman A; Novartis Institutes for Biomedical Research, Cambridge, MA, United States.
Gomez-Mancilla B; Novartis Institutes for Biomedical Research, Basel, Switzerland.
Biliouris K; Novartis Institutes for Biomedical Research, Cambridge, MA, United States.
Deurinck M; Novartis Institutes for Biomedical Research, Basel, Switzerland.
Cormack F; Cambridge Cognition, Cambridge, United Kingdom.
Anderson JJ; Neurotrack Technologies, Inc., Redwood City, CA, United States.
Bott NT; Department of Medicine, School of Medicine, Stanford University, Stanford, CA, United States.
Peremen Z; ElMindA Ltd., Herzliya, Israel.
Issachar G; ElMindA Ltd., Herzliya, Israel.
Laufer O; ElMindA Ltd., Herzliya, Israel.
Joachim D; Sonde Health, Inc., Boston, MA, United States.
Jagesar RR; Groningen Institute for Evolutionary Life Sciences, University of Groningen, Groningen, Netherlands.
Jongs N; Groningen Institute for Evolutionary Life Sciences, University of Groningen, Groningen, Netherlands.
Kas MJ; Groningen Institute for Evolutionary Life Sciences, University of Groningen, Groningen, Netherlands.
Zhuparris A; Centre for Human Drug Research, Leiden, Netherlands.
Zuiker R; Centre for Human Drug Research, Leiden, Netherlands.
Recourt K; Centre for Human Drug Research, Leiden, Netherlands.
Zuilhof Z; Centre for Human Drug Research, Leiden, Netherlands.
Cha JH; Novartis Institutes for Biomedical Research, Cambridge, MA, United States.
Jacobs GE; Centre for Human Drug Research, Leiden, Netherlands.; Department of Psychiatry, Leiden University Medical Center, Leiden, Netherlands.
Pokaż więcej
Źródło:
Frontiers in psychiatry [Front Psychiatry] 2021 May 06; Vol. 12, pp. 640741. Date of Electronic Publication: 2021 May 06 (Print Publication: 2021).
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Solving the crisis in psychopharmacological research: Cellular-membrane(s) pharmacology to the rescue?
Autorzy:
Drukarch B; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Anatomy and Neurosciences, Amsterdam Neuroscience, De Boelelaan 1117, Amsterdam, the Netherlands. Electronic address: .
Jacobs GE; Centre for Human Drug Research, Leiden, the Netherlands; Department of Psychiatry, Leiden University Medical Center, Leiden, the Netherlands.
Wilhelmus MMM; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Anatomy and Neurosciences, Amsterdam Neuroscience, De Boelelaan 1117, Amsterdam, the Netherlands.
Pokaż więcej
Źródło:
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2020 Oct; Vol. 130, pp. 110545. Date of Electronic Publication: 2020 Jul 27.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Cell Membrane/*drug effects
Psychopharmacology/*trends
Psychotropic Drugs/*pharmacology
Psychotropic Drugs/*therapeutic use
Research/*trends
Animals ; Humans ; Mental Disorders/drug therapy
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies